Skip to main content

Unicycive Therapeutics, Inc.

UNCY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001766140

No open-market purchases or sales by Unicycive Therapeutics, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $54.6M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Unicycive Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
10
+10 vs. Q2 2021
Shares held
1.07M
+1.07M vs. Q2 2021
Total value
$3.02M
+$3.02M vs. Q2 2021
New holders
10
0 more added
Sold out
0
0 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting UNCY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 10 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 10 institutionsQ4 2021: 12 institutionsQ1 2022: 12 institutionsQ2 2022: 15 institutionsQ3 2022: 12 institutionsQ4 2022: 9 institutionsQ1 2023: 13 institutionsQ2 2023: 15 institutionsQ3 2023: 16 institutionsQ4 2023: 16 institutionsQ1 2024: 23 institutionsQ2 2024: 24 institutionsQ3 2024: 29 institutionsQ4 2024: 31 institutionsQ1 2025: 29 institutionsQ2 2025: 20 institutionsQ3 2025: 30 institutionsQ4 2025: 35 institutionsQ1 2026: 51 institutionsQ2 2026: 79 institutions
Value heldQ3 2021: $3.02M
Q1 2021: $0Q2 2021: $0Q3 2021: $3.02MQ4 2021: $2.30MQ1 2022: $1.48MQ2 2022: $992.0KQ3 2022: $571.0KQ4 2022: $428.3KQ1 2023: $3.54MQ2 2023: $1.38MQ3 2023: $12.2MQ4 2023: $11.3MQ1 2024: $31.6MQ2 2024: $9.52MQ3 2024: $19.1MQ4 2024: $49.0MQ1 2025: $34.5MQ2 2025: $24.6MQ3 2025: $27.4MQ4 2025: $47.5MQ1 2026: $65.2MQ2 2026: $54.6M
Institutions holding UNCY and their total value by quarter
QuarterHoldersValue
Q2 202679$54.6M
Q1 202651$65.2M
Q4 202535$47.5M
Q3 202530$27.4M
Q2 202520$24.6M
Q1 202529$34.5M
Q4 202431$49.0M
Q3 202429$19.1M
Q2 202424$9.52M
Q1 202423$31.6M
Q4 202316$11.3M
Q3 202316$12.2M
Q2 202315$1.38M
Q1 202313$3.54M
Q4 20229$428.3K
Q3 202212$571.0K
Q2 202215$992.0K
Q1 202212$1.48M
Q4 202112$2.30M
Q3 202110$3.02M
Q2 20210$0
Q1 20210$0

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Unicycive Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding UNCY in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC700,000$1.98M0.12%+700,000New
Board of Trustees of The Leland Stanford Junior University247,583$700.0K0.05%+247,583New
Geode Capital Management, LLC26,109$73.0K0.00%+26,109New
Two Sigma Investments, LP25,551$72.0K0.00%+25,551New
Sanders Morris Harris LLC20,000$57.0K0.01%+20,000New
Frontier Wealth Management LLC18,838$53.0K0.00%+18,838New
Tandem Capital Management Corp15,500$44.0K0.03%+15,500New
BlackRock Inc.11,443$33.0K0.00%+11,443New
UBS Group AG621$2.00K0.00%+621New
Wells Fargo & Company32$00.00%+32New